The Global Arteriovenous Malformation Treatment Market is driven by Rising Incidence Rates of Arteriovenous Malformations

Arteriovenous malformation (AVM) is an abnormal tangle of blood vessels connecting arteries and veins, which disrupts normal blood circulation and oxygenation. AVMs are most commonly detected in the brain and spinal cord, though they can develop in other parts of the body as well. Treatment of AVMs aims to eradicate the tangled vascular formation in order to restore normal blood flow and prevent life-threatening hemorrhaging. Embolization and surgical resection are two key approaches employed for AVM treatment. The global AVM treatment market offers a wide range of advanced embolic agents, surgical tools and navigation systems that facilitate the targeted elimination of these vascular anomalies.

The arteriovenous malformations market is estimated to be valued at USD 3.14 Bn in 2024 and is expected to reach USD 4.99 Bn by 2031, growing at a compound annual growth rate (CAGR) of 6.8% from 2024 to 2031.

Aeteriovenous Malformation Market -https://www.coherentmi.com/ind....ustry-reports/arteri